- Home
- PROK vs OPAL Comparison
PROK vs OPAL Comparison
Compare PROK & OPAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- OPAL
- Stock Information
- Founded
- PROK 2015
- OPAL 1998
- Country
- PROK United States
- OPAL United States
- Employees
- PROK N/A
- OPAL N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- OPAL Natural Gas Distribution
- Sector
- PROK Health Care
- OPAL Utilities
- Exchange
- PROK Nasdaq
- OPAL Nasdaq
- Market Cap
- PROK 85.5M
- OPAL 90.7M
- IPO Year
- PROK N/A
- OPAL N/A
- Fundamental
- Price
- PROK $4.74
- OPAL $2.51
- Analyst Decision
- PROK Buy
- OPAL Hold
- Analyst Count
- PROK 4
- OPAL 3
- Target Price
- PROK $5.33
- OPAL $3.00
- AVG Volume (30 Days)
- PROK 33.1M
- OPAL 298.6K
- Earning Date
- PROK 08-08-2025
- OPAL 08-06-2025
- Dividend Yield
- PROK N/A
- OPAL N/A
- EPS Growth
- PROK N/A
- OPAL N/A
- EPS
- PROK N/A
- OPAL 0.02
- Revenue
- PROK $306,000.00
- OPAL $320,427,000.00
- Revenue This Year
- PROK $54.34
- OPAL $22.40
- Revenue Next Year
- PROK N/A
- OPAL $19.75
- P/E Ratio
- PROK N/A
- OPAL $126.70
- Revenue Growth
- PROK N/A
- OPAL 15.22
- 52 Week Low
- PROK $0.46
- OPAL $1.26
- 52 Week High
- PROK $7.13
- OPAL $4.45
- Technical
- Relative Strength Index (RSI)
- PROK 92.14
- OPAL 41.23
- Support Level
- PROK $0.54
- OPAL $2.54
- Resistance Level
- PROK $7.13
- OPAL $2.71
- Average True Range (ATR)
- PROK 0.62
- OPAL 0.17
- MACD
- PROK 0.47
- OPAL -0.04
- Stochastic Oscillator
- PROK 68.59
- OPAL 22.09
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About OPAL OPAL Fuels Inc.
OPAL Fuels Inc is a fully integrated, nationwide leader in the production and distribution of low-carbon intensity renewable natural gas. The company is also engaged in the marketing and distribution of RNG to heavy-duty trucking and other hard-to-de-carbonize industrial sectors. The company designs, develops, constructs, operates, and services Fueling Stations for trucking fleets across the country that use natural gas to displace diesel as their transportation fuel. The company derives revenue from the sale of Renewable Power, design, development, construction, and service of Fueling Stations, and sales of RNG produced by OPAL and third parties as pipeline-quality natural gas.